Items tagged with Medicines
TB Alliance moves two novel TB drugs into human trials (post)
GUADALAJARA (10 October, 2017) — TBA-7371 and sutezolid entered phase 1 clinical trials, TB Alliance announced today. Both compounds have proceeded through early preclinical development and were granted “Investigative New Drug” status by the U.S. Food and Drug Administration. The phase 1 clinical trials are presently ongoing.
Consortium of X-Chem, Harvard T.H. Chan School of Public Health and other leading academic institutions wins research award from the Department of Defense (post)
– Funding of $9.9 million by Department of Defense, Congressionally Directed Medical Research Programs to discover new treatments for TB
– Collaboration leverages unique genetic expertise and X-Chem’s proprietary DEXTM Platform to identify novel drugs against the deadly infectious disease
India moving forward in research towards new tools for TB (post)
-- Indigenously developed point-of-care (POC) molecular diagnostic test validated through multi-centric studies and found to be comparable with internationally approved molecular diagnostic test
Gastric acid suppressant lansoprazole may target TB (post)
A cheap and widely used drug, used to treat conditions such as heartburn, gastritis and ulcers, could work against the bacteria that cause tuberculosis (TB), according to new research from UCL and the London School of Hygiene & Tropical Medicine.
Cipla launches Q-TIB globally (post)
Cipla launches Q-TIB globally, a novel fixed dose combination in a single tablet for TB prophylaxis in HIV.
New TB drugs possible with understanding of old antibiotic (post)
Tuberculosis, and other life-threatening microbial diseases, could be more effectively tackled with future drugs, thanks to new research into an old antibiotic by the University of Warwick and The Francis Crick Institute.
Otsuka to advance development of novel TB compound (post)
Otsuka awarded grant to advance development of novel TB compound OPC-167832 with delamanid
Essential drugs missing in India’s pharmacies (post)
[BANGALORE] India, dubbed as the ‘pharmacy of the developing world’ due to its vast generic drug exports, may not be doing enough to ensure availability of essential medicines in its domestic market, a new Indo-British study suggests.
Indian scientists find asthma drug useful in TB as well (post)
Indian Institute of Science, Bengaluru, found that an existing anti-asthma drug is effective against tuberculosis and can help address the problem of drug resistance as well
WHO launches plan for cheaper TB drugs (post)
The World Health Organisation (WHO), on Tuesday (March 6), invited pharmaceutical companies around the world to submit proposals to manufacture affordable versions of newer medicines for treatment of drug-resistant tuberculosis (DR-TB).
Page 8 of 19 · Total posts: 0
←First 7 8 9 Last→